 민기준 교수 E-mail : beichest@catholic.ac.kr |
|
연구분야 림프종 및 만성림프구성 백혈병 자가 및 동종 조혈모세포이식 세포면역치료제 성체중간엽줄기세포와 면역조절세포를 이용한 병용세포치료 기반 면역조절연구 사이토카인유도킬러세포를 이용한 림프종 항암환자 유지치료 및 면역조절 연구 |
|
학력사항 한양대학교 생명과학전공 이학사 (2008) 경희대학교 의학과 의무석사 (2012) 가톨릭대학교 대학원 내과학 박사 (2020) |
|
경력사항 가톨릭대학교 서울성모병원 수련의 (2012-2013) 가톨릭대학교 서울성모병원 내과 전공의 (2013-2016) 가톨릭대학교 서울성모병원 혈액내과 임상강사 (2017-2018) 가톨릭대학교 서울성모병원 혈액내과 임상진료조교수 (2019-2022) 가톨릭대학교 서울성모병원 혈액내과 조교수 (2023-현재) 가톨릭대학교 혈액병원 림프종센터장 (2025-현재) |
|
주요 연구물 1. Min G-J, Jeon Y-W, Kim TY, et al. The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma. Scientific Reports. 2023;13(1):17496. 2. Min GJ, Rhee CK, Kim TY, et al. Long-term Clinical Outcomes of Optimizing Combination Therapy for Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma: A Retrospective Study. Acta Haematol. 2023. 3. Min GJ, Kim TY, Jeon YW, et al. Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single-center real-world clinical experience. Cancer Med. 2023;12(7):7911-7922. 4. Min GJ, Kang D, Lee HH, et al. Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma in real-world experience. Ann Hematol. 2023;102(4):877-888. 5. Min G-J, Kim SE, Kim TY, et al. Long-Term Clinical Outcomes in Treatment-Naïve Patients With Orbital Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma: A Single-Center Study. Frontiers in Oncology. 2022;12. 6. Min G-J, Jeon Y-W, Kim TY, et al. Long-term treatment outcome of Castleman’s disease: A real-world experience. Frontiers in Oncology. 2022;12. 7. Min G-J, Cho B-S, Park S-S, et al. Geriatric assessment predicts nonfatal toxicities and survival for intensively treated older adults with AML. Blood. 2022;139(11):1646-1658. 8. Min GJ, Jeon YW, Park SS, et al. The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman's disease. Korean J Intern Med. 2021;36(2):424-432. 9. Cho BS, Min GJ, Park SS, et al. Low-dose thymoglobulin for prevention of chronic graft-versus-host disease in transplantation from an HLA-matched sibling donor. Am J Hematol. 2021;96(11):1441-1449. 10. Min G-J, Kim H-J, Kim T-G, et al. Specific donor HLA allotypes as predictors of cytomegalovirus disease risk in acute myeloid leukemia. HLA. 2020;96(4):445-455. |
